Evidence map›Paper›PMID 39500848›Full record

ArticleReproductive sciences (Thousand Oaks, Calif.)2024

Establishment of 3D Cultures of Myometrium, Leiomyoma, and Leiomyosarcoma Cells: Advantages and Disadvantages of Two Different Models.

Pamela Pellegrino, Stefania Greco, Abel Duménigo Gonzàlez, Francesca Giampieri, Stefano Raffaele Giannubilo, Giovanni Delli Carpini, Franco Capocasa, Bruno Mezzetti, Maurizio Battino, Andrea Ciavattini and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Reproductive sciences (Thousand Oaks, Calif.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. An Ex Vivo Model for the Onset of Human Labor.Reproductive sciences (Thousand Oaks, Calif.) · 2026
    Article
  2. Review
  3. Review
  4. Modeling Uterine Fibroids Using Bioengineered Hydrogels.ACS biomaterials science & engineering · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Pamela Pellegrino *Department of Experimental and Clinical Medicine, Faculty of Medicine, Università Politecnica Delle Marche, Via Tronto 10/a, 60020, Ancona, Italy.
Stefania Greco *Department of Experimental and Clinical Medicine, Faculty of Medicine, Università Politecnica Delle Marche, Via Tronto 10/a, 60020, Ancona, Italy.
Abel Duménigo GonzàlezDepartment of Experimental and Clinical Medicine, Faculty of Medicine, Università Politecnica Delle Marche, Via Tronto 10/a, 60020, Ancona, Italy.
Francesca GiampieriDepartment of Clinical Science, Università Politecnica Delle Marche, Ancona, Italy.
Stefano Raffaele GiannubiloDepartment of Clinical Science, Università Politecnica Delle Marche, Ancona, Italy.
Giovanni Delli CarpiniDepartment of Clinical Science, Università Politecnica Delle Marche, Ancona, Italy.
Franco CapocasaDepartment of Agricultural, Food, and Environmental Sciences, Università Politecnica Delle Marche, Ancona, Italy.
Bruno MezzettiDepartment of Agricultural, Food, and Environmental Sciences, Università Politecnica Delle Marche, Ancona, Italy.
Maurizio BattinoDepartment of Clinical Science, Università Politecnica Delle Marche, Ancona, Italy.
Andrea CiavattiniDepartment of Clinical Science, Università Politecnica Delle Marche, Ancona, Italy.
Pasquapina CiarmelaDepartment of Experimental and Clinical Medicine, Faculty of Medicine, Università Politecnica Delle Marche, Via Tronto 10/a, 60020, Ancona, Italy. p.ciarmela@univpm.it.ORCID 0000-0002-4400-3786

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uterine leiomyomas are the most common benign, monoclonal, gynaecological tumors in a woman's uterus, while leiomyosarcoma is a rare but aggressive condition caused by the malignant transformation of the myometrium. To overcome the common obstacles related to the methods usually used to study these pathologies, we aimed to devise three-dimensional models of myometrium, uterine leiomyoma and leiomyosarcoma cell lines, using two different types of biocompatible scaffolds. Specifically, we exploited the agarose gel matrix in common 6-well plates and the alginate matrix using Bioprinting INKREDIBLE + (CELLINK), a pneumatic extruded base equipped with a system with double printheads, and a UV printer LED curing system. Both methods allowed the development of 3D spheroids of all three cell types, that were also suitable for morphological investigations. We showed that all cell types embedded in both agarose and alginate formed spheroids in their growth medium. The spheroids successfully proliferated and self-organized into complex structures, developing a sustainable system that emulated the condition of the tissues through the accumulation of extracellular matrix. These models could be useful for a better understanding of pathophysiology, etiopathogenesis, and testing new methods or molecules from a preventive and therapeutic point of view.

Indexed as

Cell Culture Techniques, Three DimensionalLeiomyomaLeiomyosarcomaMyometriumSpheroids, CellularUterine NeoplasmsAlginatesCell Culture TechniquesCell Line, TumorCell ProliferationFemaleHumansSepharoseTissue ScaffoldsAlginatesSepharose3D BioprinterAgaroseLeiomyomaLeiomyosarcomaMyometriumSpheroid

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.